ASCEND BY NTHRYS
Research Abroad Products

Personalized Medicine Project Topics

Browse all focused areas across all project categories under this field.

Showing 109–120 of 200 project topics
Clinical-Grade Liquid Biopsy Data Integration Platform
A HIPAA-compliant data integration platform that consolidates liquid biopsy results with genomic, clinical, and outcomes data across multiple testing providers and healthcare systems. Generates revenue through enterprise licensing fees, data standardization services, and analytics licensing to biopharmaceutical companies conducting real-world evidence studies.
Liquid Biopsy Personalized Medicine Dev Click to view more details →
Precision Oncology Decision Support Engine for Liquid Biopsies
An AI-driven clinical decision support system that interprets liquid biopsy biomarkers alongside tumor genomics to recommend personalized therapy combinations and monitoring schedules. Monetizes through licensing to comprehensive cancer centers, integration fees with major EHR vendors, and performance-based revenue sharing with healthcare providers improving treatment outcomes.
Liquid Biopsy Personalized Medicine Dev Click to view more details →
Real-Time Genomic Sequencing and Interpretation SaaS Platform
A cloud-based platform that processes whole genome and exome sequencing data with AI-powered variant calling and clinical annotation in under 24 hours. This enables laboratories and hospitals to monetize sequencing services faster while reducing turnaround time by 70%, creating recurring subscription revenue from healthcare providers.
Companion Diagnostic Technology Platform Click to view more details →
Predictive Biomarker Discovery Engine for Drug Development
An enterprise software solution that identifies patient-specific biomarkers and predicts therapeutic response using machine learning on multi-omics datasets before clinical trials. Pharmaceutical companies license this platform to accelerate drug development timelines and increase clinical trial success rates, commanding premium licensing fees of $500K-$2M annually.
Companion Diagnostic Technology Platform Click to view more details →
Pharmacogenomic Testing Laboratory Information Management System
A specialized LIMS and billing platform designed for pharmacogenomics testing labs that automates sample tracking, result reporting, and insurance claim submission for medication response predictions. This white-label solution generates revenue through per-test processing fees while reducing administrative overhead by 60% for clinical laboratories.
Companion Diagnostic Technology Platform Click to view more details →
Patient Genetic Risk Stratification and Management Dashboard
A clinician-facing web and mobile application that aggregates genetic, clinical, and lifestyle data to automatically stratify patient risk levels and recommend personalized intervention protocols. Healthcare systems and insurers deploy this platform to improve preventive care outcomes while generating data-driven insights that support risk-based payment models and population health contracts.
Companion Diagnostic Technology Platform Click to view more details →
Multi-Cancer Early Detection Blood Test Commercial Distribution Platform
An end-to-end commercial platform that manages ordering, sample collection, sequencing, and result delivery for liquid biopsy-based multi-cancer detection tests directly to consumers and providers. The platform scales revenue through direct-to-consumer marketing, B2B provider partnerships, and insurance reimbursement processing, achieving gross margins above 70%.
Companion Diagnostic Technology Platform Click to view more details →
Immunotherapy Response Prediction AI Platform for Oncology
A machine learning platform that analyzes tumor microenvironment genomics and immune cell profiling to predict which cancer patients will respond to immunotherapy before treatment initiation. Oncology centers and cancer networks license this tool to improve treatment selection accuracy, reduce drug waste, and improve patient outcomes, supporting premium pricing of $10K-$50K per deployment.
Companion Diagnostic Technology Platform Click to view more details →
Rare Disease Genetic Variant Interpretation and Licensing Service
A curated knowledge platform and API service that provides clinical laboratories and genetic counselors with validated variant interpretations and disease-gene associations for rare and ultra-rare conditions. This B2B SaaS service generates recurring revenue from laboratory subscriptions while reducing liability through expert-curated interpretations that meet regulatory compliance standards.
Companion Diagnostic Technology Platform Click to view more details →
Tumor-Agnostic Molecular Matching and Clinical Trial Enrollment Platform
A commercial platform that matches cancer patients to appropriate clinical trials based on molecular profile rather than cancer type, using comprehensive genomic profiling data. Pharmaceutical sponsors and academic medical centers use this tool to accelerate trial enrollment, improve recruitment efficiency, and identify better-matched patient cohorts, generating transaction fees and subscription revenue.
Companion Diagnostic Technology Platform Click to view more details →
Polygenic Risk Score Commercial Deployment and Consumer Reporting Tool
A white-label platform that enables direct-to-consumer genetic testing companies and healthcare providers to calculate, validate, and deliver polygenic risk scores for common diseases with personalized health recommendations. This B2B2C solution generates revenue through licensing fees, per-report transaction payments, and premium health coaching service add-ons that increase customer lifetime value.
Companion Diagnostic Technology Platform Click to view more details →
Infectious Disease Pathogen Genomics Surveillance and Reporting Network
A cloud-based network platform that aggregates real-time whole-genome sequencing data from diagnostic laboratories to track pathogen variants, antibiotic resistance patterns, and outbreak dynamics across healthcare systems. Public health agencies and hospital networks subscribe to this platform for epidemiological intelligence, enabling faster outbreak response and informing treatment protocols while securing government contracts and grants.
Companion Diagnostic Technology Platform Click to view more details →